View Author
cancer breast patient study breast cancer tumor brca 1 mutation carrier breast cancer risk university association group survival department research table center chemotherapy genetic family factor analysis women hospital density signi ficantly fi rst-line chemotherapy 2-associated status genetics service case patients mammography signi characteristic institute bi-rad 1/2 difference tumor subtypes receptor centre subtype breast cancer res oncology response brca 1- diagnosis risk factors breast cancer patients article disease cohort result ficantly analyses tumour therapy adjuvant 1-associated metastatic service treatment brca 2 mutations estimate breast density netherland downloaded american family history metastatic breast cancer medicine non-brca foundation brca 2 health agreement category erasmu grant
10 Most Recent Publications
|
The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling
(Article)
Vencken, P.M.L.H. Kriege, M. Seynaeve, C.M. Hooning, M. Menke-Pluymers, M.B.E. Heemskerk-Gerritsen, B.A.M. Doorn, L.C. van Collee, J.M. Jager, A. Montfort, C.A.G.M. van Burger, C.W. |
2013-03-01
|
|
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
(Article)
Vencken, P.M.L.H. Kriege, M. Seynaeve, C.M. Hoogwerf, D. Beugelink, S. Burg, M.E.L. van der Hooning, M. Berns, P.M.J.J. Jager, A. Collée, J.M. Burger, C.W. |
2011-06-06
|
|
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers
(Article)
Spurdle, A.B. Marquart, L. Gschwantler-Kaulich, D. Blum, J.L. Tung, N. Weitzel, J.N. Lynch, H. Garber, J. Easton, D.F. Peock, S. Cook, J. Oliver, C. McGuffog, L. Frost, D. Conroy, D. Evans, D.G. Lalloo, F. Eeles, R. Izatt, L. Davidson, R. Chu, C. Eccles, D. Selkirk, C.G. Healey, S. Daly, M. Isaacs, C. Stoppa-Lyonnet, D. Buecher, B. Belotti, M. Mazoyer, S. Barjhoux, L. Verny-Pierre, C. Lassett, C. Dreyfus, H. Sinilnikova, O. Pujol, P. Collonge-Rame, M.-A. Rookus, M.A. Verhoef, S. Kriege, M. Hoogerbrugge, N. Ausems, M.G.E.M. Os, T.A.M. van Wijnen, J.T. Devilee, P. Wan, F. Meijers-Heijboer, H. Blok, M.J. Heikinen, T. Nevanlinna, H. Jakubowska, A. Lubinski, J. Huzarski, T. Byrski, T. Durocher, F. Couch, F.J. Chenevix-Trench, G. Lindor, N.M. Wang, X. Thomassen, M. Domchek, S.M. Nathanson, K.L. Caligo, M.A. Jernström, H. Liljegren, A. Ehrencrona, H. Karlsson, P. Beesley, J. Ganz, P.A. Olopade, O.I. Tomlinson, G. Neuhausen, S.L. Antoniou, A.C. Chenevix-Trench, G. Rebbeck, T.R. Singer, C.F. Dressler, A.-C. |
2011-05-01
|
|
Associations of breast cancer risk factors with tumor subtypes: A pooled analysis from the breast cancer association consortium studies
(Article)
Yang, X.R. Chang-Claude, J. Fasching, P.A. Shen, C.-Y. Hsiung, C.-N. Wu, P.E. Yu, J.-C. Chen, S.-T. Hsu, G.-C. Haiman, C.A. Henderson, B.E. Le Marchand, L. Kolonel, L.N. Hein, R. Lindblom, A. Margolin, S. Jakubowska, A. Lubinski, J. Huzarski, T. Byrski, T. Górski, B. Gronwald, J. Hooning, M. Hollestelle, A. Spurdle, A.B. Ouweland, A.M.W. van den Jager, A. Kriege, M. Tilanus-Linthorst, M.M.A. Collee, J.M. Wang-Gohrke, S. Pylkäs, K. Jukkola-Vuorinen, A. Mononen, K. Grip, M. Blows, F. Hirvikoski, P. Winqvist, R. Mannermaa, A. Kosma, V.M. Kauppinen, J. Kataja, V. Auvinen, P. Soini, Y. Sironen, R. Bojesen, S.E. Driver, K. Dynnes Ørsted, D. Kaur-Knudsen, D. Flyger, H. Nordestgaard, B.G. Holland, H. Chenevix-Trench, G. Manoukian, S. Barile, M. Radice, P. Hankinson, S.E. Flesch-Janys, D. Hunter, D. Tamimi, R. Sangrajrang, S. Brennan, P. McKay, J. Odefrey, F. Gaborieau, V. Devilee, P. Huijts, P. Tollenaar, R. Heinz, J. Seynaeve, C.M. Dite, G.S. Apicella, C. Hopper, J. Hammet, F. Tsimiklis, H. Smith, L. Southey, M.C. Easton, D.F. Pharoah, P. Sinn, P. Sherman, M. García-Closas, M. Vrieling, A. Heikinen, T. Goode, E.L. Aittomäki, K. Heikkilä, P. Blomqvist, C. Lissowska, J. Peplonska, B. Chanock, S.J. Figueroa, J. Brinton, L.A. Hall, A.S. Czene, k. Couch, F.J. Humphreys, M.K. Darabi, H. Liu, J. Veer, L.J. van 't Leeuwen, F.E. van Andrulis, I.L. Glendon, G. Knight, J.A. Mulligan, A.M. O'Malley, F.P. Nevanlinna, H. Weerasooriya, N. John, E.M. Beckmann, M.W. Hartmann, A. Weihbrecht, S.B. Wachter, D.L. Jud, S.M. Loehberg, C.R. Baglietto, L. English, D.R. Milne, R.L. Giles, G.G. McLean, C.A. Severi, G. Lambrechts, D. Vandorpe, T. Weltens, C. Paridaens, R. Smeets, A. Neven, P. Wildiers, H. Gaudet, M.M. Wang, X. Olson, J.E. Cafourek, V. Fredericksen, Z. Kosel, M. Vachon, C. Cramp, H.E. Connley, D. Cross, S.S. Balasubramanian, S. Schmidt, M.K. Reed, M.W.R. Dörk, T. Bremer, M. Meyer, A. Karstens, J.H. Ay, A. Park-Simon, T.-W. Hillemanns, P. Arias Pérez, J.I. Rodríguez, P.M. Broeks, A. Zamora, P. Benitez, J. Ko, Y.D. Fischer, H.-P. Hamann, U. Pesch, B. Brüning, T. Justenhoven, C. Brauch, H. Eccles, D. Cox, A. Tapper, W. Gerty, S.M. Sawyer, E.J. Tomlinson, I.P. Jones, A. Kerin, M. Miller, N. McInerney, N. Anton-Culver, H. Ziogas, A. |
2011-02-02
|
|
Association of risk-reducing surgery with cancer risks and mortality in BRCA mutation carriers
(Article)
Heemskerk-Gerritsen, B.A.M. Kriege, M. Seynaeve, C.M. |
2010-12-22
|
|
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction
(Article)
Antoniou, A.C. Beesley, J. Isaacs, C. Bonadona, V. Lassett, C. Dreyfus, H. Leroux, D. Hardouin, A. Berthet, P. Faivre, L. Loustalot, C. Noguchi, T. Sobol, H. Ganz, P.A. Rouleau, E. Nogues, C. Frenay, M. Vénat-Bouvet, L. Hopper, J. Daly, M. Terry, M-B. John, E.M. Buys, S.S. Yassin, Y. Tomlinson, G. Miron, A. Goldgar, D. Singer, C.F. Dressler, C. Gschwantler-Kaulich, D. Pfeiler, G. Hansen, T.V.O. Jnson, L. Agnarsson, B.A. Kirchhoff, T. Olopade, O.I. Offit, K. Devlin, V. Dutra-Clarke, A. Piedmonte, M. Rodriguez, G.C. Wakeley, K. Boggess, J.F. Basil, J. Schwartz, P.E. Blank, S.V. Couch, F.J. Toland, A.E. Montagna, M. Casella, C. Imyanitov, E.N. Tihomirova, L. Blanco, I. Lazaro, C. Ramus, S.J. Sucheston, L. Karlan, B.Y. Wang, X. Gross, J. Schmutzler, R.K. Wappenschmidt, B. Engel, C. Meindl, A. Lochmann, M. Arnold, N. Heidemann, S. Varon-Mateeva, R. Niederacher, D. Lindor, N.M. Sutter, C. Deissler, H. Gadzicki, D. Preisler-Adams, S. Kast, K. Schönbuchner, I. Caldes, T. Hoya, M. de La Aittomäki, K. Nevanlinna, H. Pankratz, V.S. Simard, J. Spurdle, A.B. Holland, H. Chenevix-Trench, G. Platte, R. Easton, D.F. Radice, P. Manoukian, S. McGuffog, L. Peissel, B. Zaffaroni, D. Barile, M. Viel, A. Allavena, A. Dall'Olio, V. Peterlongo, P. Szabo, C. Zikan, M. Claes, K. Sinilnikova, O. Poppe, B. Foretova, L. Mai, P.L. Greene, M.H. Rennert, G. Lejbkowicz, F. Glendon, G. Ozcelik, H. Andrulis, I.L. Thomassen, M. Healey, S. Gerdes, A-M. Sunde, L. Cruger, D. Jensen, U.B. Caligo, M.A. Friedman, E. Kaufman, B. Laitman, Y. Milgrom, R. Dubrovsky, M. Neuhausen, S.L. Cohen, S. Borg, A. Jernström, H. Lindblom, A. Rantala, J. Stenmark-Askmalm, M. Melin, B. Nathanson, K.L. Domchek, S.M. Jakubowska, A. Ding, Y.C. Lubinski, J. Huzarski, T. Osorio, A. Lasa, A. Durán, M. Tejada, M.I. Godino, J. Benitez, J. Hamann, U. Kriege, M. Rebbeck, T.R. Hoogerbrugge, N. Luijt, R.B. van der Asperen, C.J. van Devilee, P. Meijers-Heijboer, E.J. Blok, M.J. Aalfs, C. Hogervorst, F.B.L. Rookus, M.A. Cook, J. Weitzel, J. Oliver, C. Frost, D. Conroy, D. Evans, D.G. Lalloo, F. Pichert, G. Davidson, R. Cole, T.J. Paterson, J. Hodgson, S.V. Lynch, H. Morrison, P.J. Porteous, M.E. Walker, L. Kennedy, M.J. Dorkins, H. Peock, S. Godwin, A.K. Stoppa-Lyonnet, D. Pauw, A. de Mazoyer, S. |
2010-12-01
|
|
Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers
(Article)
Kriege, M. Seynaeve, C.M. Ouweland, A.M.W. van den Geel, B.N. van Hooning, M. Brekelmans, C.T. Klijn, J.G.M. Meijers-Heijboer, H. Collee, J.M. Menke-Pluymers, M.B.E. Bartels, C.C.M. Tilanus-Linthorst, M.M.A. Blom, J. Huijskens, E. Jager, A. |
2009-08-10
|
|
Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients
(Article)
Kriege, M. Seynaeve, C.M. Klijn, J.G.M. Meijers-Heijboer, E.J. Collee, J.M. Menke-Pluymers, M.B.E. Bartels, C.C.M. Tilanus-Linthorst, M.M.A. Ouweland, A.M.W. van den Geel, B.N. van Brekelmans, C.T. |
2008-09-01
|
|
Mammography: Interobserver variability in breast density assessment
(Article)
Ooms, E.A. Zonderland, H.M. Eijkemans, M.J.C. Kriege, M. Mahdavian Delavary, B. Burger, C.W. Ansink, A.C. |
2007-12-01
|
|
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
(Article)
Kriege, M. Brekelmans, C.T. Tilanus-Linthorst, M.M.A. Seynaeve, C.M. Bartels, C.C.M. Meijer, S. Oosterwijk, J.C. Hoogerbrugge, N. Tollenaar, R.A.E.M. Koning, H.J. de Rutgers, E.J.T. Klijn, J.G.M. Peterse, H. Obdeijn, I.M. Boetes, C. Zonderland, H.M. Muller, S.H. Kok, T. Manoliu, R.A. Besnard, A.P.E. |
2007-05-01
|
